Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy

Clinical trial NCT05931224 · COMPLETED

Trial details

NCT number: NCT05931224
Sponsor: Chong Kun Dang Pharmaceutical
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Essential Hypertension

Start date: 2023-06-28
Primary completion: 2024-05-13
Enrollment: 346

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.